Cash and cash equivalents (USD, millions)

Investments (USD, millions)

Accounts receivable, less allowances and credit losses (USD, millions)

Inventories (USD, millions)

Other current assets (USD, millions)

Total current assets (USD, millions)

Property, plant, and equipment, net (USD, millions)

Goodwill (USD, millions)

Other intangible assets, net (USD, millions)

Tax assets (USD, millions)

Other assets (USD, millions)

Total assets (USD, millions)

Current debt obligations (USD, millions)

Accounts payable (USD, millions)

Accrued compensation (USD, millions)

Accrued income taxes (USD, millions)

Other accrued expenses (USD, millions)

Total current liabilities (USD, millions)

Long-term debt (USD, millions)

Accrued compensation and retirement benefits (USD, millions)

Deferred tax liabilities (USD, millions)

Other liabilities (USD, millions)

Total liabilities (USD, millions)

Additional paid-in capital (USD, millions)

Retained earnings (USD, millions)

Accumulated other comprehensive loss (USD, millions)

Total shareholders’ equity (USD, millions)

Noncontrolling interests (USD, millions)

Total equity (USD, millions)

Total liabilities and equity (USD, millions)

bafc779f8a70a26cec9dba70c5a4032acc5c0add428130c5aa189ed1c26b12ee

Net Income (USD, millions)

Depreciation and Amortization (USD, millions)

Provision for Credit Losses (USD, millions)

Stock-based Compensation (USD, millions)

Loss on Debt Extinguishment (USD, millions)

Other, net (USD, millions)

Net Cash Provided by Operating Activities (USD, millions)

Acquisitions, Net of Cash Acquired (USD, millions)

Additions to Property, Plant, and Equipment (USD, millions)

Purchases of Investments (USD, millions)

Sales and Maturities of Investments (USD, millions)

Other Investing Activities, Net (USD, millions)

Net Cash Used in Investing Activities (USD, millions)

Change in Current Debt Obligations, Net (USD, millions)

Proceeds from Short-term Borrowings (maturities greater than 90 days) (USD, millions)

Issuance of Long-term Debt (USD, millions)

Payments on Long-term Debt (USD, millions)

Dividends to Shareholders (USD, millions)

Issuance of Ordinary Shares (USD, millions)

Repurchase of Ordinary Shares (USD, millions)

Other Financing Activities (USD, millions)

Net Cash (Used in) Provided by Financing Activities (USD, millions)

Effect of Exchange Rate Changes on Cash and Cash Equivalents (USD, millions)

Net Change in Cash and Cash Equivalents (USD, millions)

Income Taxes Paid (USD, millions)

Interest Paid (USD, millions)

Deferred Income Taxes (USD, millions)

Cash and Cash Equivalents at Beginning of Period (USD, millions)

Cash and Cash Equivalents at End of Period (USD, millions)

58bc4c31399d83174d1214746a34ac6b4b49e94fccbe6583fb12d562dbc7eac4

Net sales (USD, millions)

Cost of products sold, excluding amortization of intangible assets (USD, millions)

Research and development expense (USD, millions)

Selling, general, and administrative expense (USD, millions)

Amortization of intangible assets (USD, millions)

Restructuring charges, net (USD, millions)

Certain litigation charges, net (USD, millions)

Other operating expense (income), net (USD, millions)

Operating profit (USD, millions)

Other non-operating income, net (USD, millions)

Interest expense, net (USD, millions)

Income before income taxes (USD, millions)

Income tax provision (USD, millions)

Net income (USD, millions)

Net income attributable to noncontrolling interests (USD, millions)

Net income attributable to Medtronic (USD, millions)

Basic earnings per share (USD)

Diluted earnings per share (USD)

Basic weighted average shares outstanding (Millions)

Diluted weighted average shares outstanding (Millions)

1994df3118f06a550a8e3e38af9a2d4b73fdb2ef14d1f6d47a5eb9c956f03a93

Adjustments for Non-Cash Items

Stock-Based Compensation

Changes in Working Capital

Capital Expenditures (CapEx)

Proceeds from / Repayments of Debt

Share Repurchases

Dividend Payments

Net Change in Cash

8cf89dbe2c661bad82e3730f81022599fc69272706e6c37f790d05ef1bba3e2e

Total Revenue [USD, Millions]

Cost of Goods Sold (COGS) [USD, Millions]

SG&A [USD, Millions]

R&D [USD, Millions]

D&A [USD, Millions]

Interest Expense [USD, Millions]

Operating Income (EBIT) [USD, Millions]

Net Income [USD, Millions]

EPS - Basic [USD]

EPS - Diluted [USD]

5adb0fb6cf5e4dad31c13663ec4ec248396d5d9443d46ae8afc5cc88f50a135c

5f0e6cac76edbf210fda71446e8d66e100107a9f4f1dd1916d0842450883b200

Number of facilities in Israel (facilities)

Number of employees in Israel (employees)

753c7658ac5a411fe1e22908da7178d0ee2042cb5e818a59fc5384feac5b37dd

U.S.

Non-U.S. Developed Markets

Emerging Markets

- Ireland

- Rest of World

International

Americas

EMEA (Europe, Middle East, and Africa)

Asia-Pacific

Greater China

Total Revenue

56d327e12b45afb050dc5da330a26b40010e0c5ddd2ee85585f7f241c09095f0

6a71ae12ff7bae451f896a0bcb1fc106b3d13fa8a89a0b3ded458e3eb5004796

Medtronic (MDT)

Financials